erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
embolization “cuts off the blood supply to a certain part of the body,” according to the national institutes of health. .
senator: sir, i have the numbers in front of me. how can you keep this secret from the public? . .